• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Health Net reviews businesses

Article

Analysts speculate Health Net will sell off businesses in key states where it's not the market leader.

Analysts are speculating that Health Net will sell off its businesses in key states where it is not the market leader, including New York, New Jersey, Connecticut and Arizona.

“We are engaged in a strategic review of all our businesses,” according to a Health Net statement. “We have a strong network and a strong base of customers and loyal associates. We are reviewing whether there are potential partnerships with others that will allow us to better serve our customers and strengthen the provider networks that serve them.”

National companies such as UnitedHealth, Aetna and CIGNA operate in many states with lower market share, and this fits in their business model given their true national presence, according to Clive Riddle, president and founder of Modesto, Calif.-based MCOL, a provider of business-to-business health management and managed care resources.

“But for a smaller organization with multi-regional presence, the business model is somewhat different and the business and market pressures are different,” Riddle says. “Thus it is understandable that Health Net would pursue this strategy, but that does not necessarily mean that the national organizations will go down the same path.”

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.